These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31847538)

  • 21. Growing significance of myeloperoxidase in non-infectious diseases.
    Hoy A; Leininger-Muller B; Kutter D; Siest G; Visvikis S
    Clin Chem Lab Med; 2002 Jan; 40(1):2-8. PubMed ID: 11916266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.
    Maruyama Y; Lindholm B; Stenvinkel P
    J Nephrol; 2004; 17 Suppl 8():S72-6. PubMed ID: 15599890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (sST2), Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT).
    Li J; Cao T; Wei Y; Zhang N; Zhou Z; Wang Z; Li J; Zhang Y; Wang S; Wang P; Cheng N; Ye L; Li M; Yu Y; Ding C; Tan Z; Zhan B; He Q; Bao H; Wu Y; Liu L; Li J; Xu X; Cheng X; Huang X
    Dis Markers; 2021; 2021():6258865. PubMed ID: 34422136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.
    Teng N; Maghzal GJ; Talib J; Rashid I; Lau AK; Stocker R
    Redox Rep; 2017 Mar; 22(2):51-73. PubMed ID: 27884085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloperoxidase Inhibitors as Potential Drugs.
    Lazarević-Pasti T; Leskovac A; Vasić V
    Curr Drug Metab; 2015; 16(3):168-90. PubMed ID: 26279325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic Guaiacol Derivatives as Promising Myeloperoxidase Inhibitors Targeting Atherosclerotic Cardiovascular Disease.
    Premkumar J; Sampath P; Sanjay R; Chandrakala A; Rajagopal D
    ChemMedChem; 2020 Jul; 15(13):1187-1199. PubMed ID: 32368837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of plasma myeloperoxidase in ESRD patients.
    Wang AY; Lam CW; Chan IH; Wang M; Lui SF; Sanderson JE
    Am J Kidney Dis; 2010 Nov; 56(5):937-46. PubMed ID: 20638167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes.
    Loria V; Dato I; Graziani F; Biasucci LM
    Mediators Inflamm; 2008; 2008():135625. PubMed ID: 18382609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum myeloperoxidase and mortality in maintenance hemodialysis patients.
    Kalantar-Zadeh K; Brennan ML; Hazen SL
    Am J Kidney Dis; 2006 Jul; 48(1):59-68. PubMed ID: 16797387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment.
    Brennan ML; Hazen SL
    Curr Opin Lipidol; 2003 Aug; 14(4):353-9. PubMed ID: 12865732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of monocyte myeloperoxidase with incident cardiovascular disease: The Atherosclerosis Risk in Communities Study.
    Oyenuga AO; Couper D; Matsushita K; Boerwinkle E; Folsom AR
    PLoS One; 2018; 13(10):e0205310. PubMed ID: 30300402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of myeloperoxidase on HDL function in myocardial infarction.
    Tietge UJF
    Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):137-142. PubMed ID: 29356689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of myeloperoxidase in cardiology.
    Ikitimur B; Karadag B
    Future Cardiol; 2010 Sep; 6(5):693-702. PubMed ID: 20932115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease].
    Grigorieva DV; Gorudko IV; Kostevich VA; Sokolov AV; Buko IV; Vasilyev VB; Polonetsky LZ; Panasenko OM; Cherenkevich SN
    Biomed Khim; 2016 Mar; 62(3):318-24. PubMed ID: 27420626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.
    Baldus S; Heeschen C; Meinertz T; Zeiher AM; Eiserich JP; Münzel T; Simoons ML; Hamm CW;
    Circulation; 2003 Sep; 108(12):1440-5. PubMed ID: 12952835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil-derived myeloperoxidase promotes atherogenesis and neointima formation in mice.
    Tiyerili V; Camara B; Becher MU; Schrickel JW; Lütjohann D; Mollenhauer M; Baldus S; Nickenig G; Andrié RP
    Int J Cardiol; 2016 Feb; 204():29-36. PubMed ID: 26655530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study.
    Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Strom A; Bönhof GJ; Heier M; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D
    Diabetes Metab Res Rev; 2018 Jul; 34(5):e3000. PubMed ID: 29577557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloperoxidase and cardiovascular disease.
    Nicholls SJ; Hazen SL
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1102-11. PubMed ID: 15790935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction.
    Mocatta TJ; Pilbrow AP; Cameron VA; Senthilmohan R; Frampton CM; Richards AM; Winterbourn CC
    J Am Coll Cardiol; 2007 May; 49(20):1993-2000. PubMed ID: 17512353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.